Therapy with m-TOR inhibitors decreases the response to the pandemic influenza a H1N1 vaccine in solid organ transplant recipients

American Journal of Transplantation

Volumn 11, Issue 10, 2011, Pages 2205-2213

  Cordero, E ^a   Perez Ordonez A ^a   Aydillo, T A ^a   Torre Cisneros, J ^b   Gavalda, J ^c   Lara, R ^b   Segura, C ^b   Len, O ^c   Cabral, E ^c   Gasch, A ^a   Pachon, J ^a   Perez Romero, P ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Immune response; influenza A H1N1 vaccine; mTOR inhibitors; solid organ transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN; INFLUENZA VACCINE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ANTIBODY TITER; ARTICLE; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA VACCINATION; LIVER DISEASE; MALE; PRIORITY JOURNAL; SEROCONVERSION; SOLID ORGAN TRANSPLANT RECIPIENT;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; NEUTRALIZATION TESTS; ORGAN TRANSPLANTATION; TOR SERINE-THREONINE KINASES;

EID: 81155161821     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03692.x     Document Type: Article

References (27)

1. Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 467-470.
2. Ison MG,. Respiratory viral infections in transplant recipients. Antivir Ther 2007; 12 (Pt B): 627-638. (Pubitemid 47235505)
3. Vilchez R, McCurry K, Dauber J, et al,. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients. Transplantation 2002; 73: 1075-1078. (Pubitemid 34415437)
4. Vilchez RA, Fung J, Kusne S,. The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis 2002; 4: 177-182. (Pubitemid 36142802)
5. Klimov AI, Rocha E, Hayden FG, Shult PA, Roumillat LF, Cox NJ,. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: Detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172: 1352-1355.
6. Kunisaki KM, Janoff EN,. Influenza in immunosuppressed populations: A review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9: 493-504.
7. Kumar D, Michaels MG, Morris MI, et al,. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: A multicentre cohort study. Lancet Infect Dis 2010; 10: 521-526.
8. Danzinger-Isakov L, Kumar D,. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009; 9 (Suppl 4): S258-S262.
9. Birdwell KA, Ikizler MR, Sannella EC, et al,. Decreased antibody response to influenza vaccination in kidney transplant recipients: A prospective cohort study. Am J Kidney Dis 2009; 54: 112-121.
10. Blumberg EA, Albano C, Pruett T, et al,. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22: 295-302. (Pubitemid 26056158)
11. Morales JM, Andres A, Dominguez-Gil B, et al,. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: Unicentric results of the tacrolimus versus cyclosporine: A European Multicentric Study in kidney transplant patients. Transplant Proc 2005; 37: 3738-3742. (Pubitemid 43015151)
12. Wullschleger S, Loewith R, Hall MN,. TOR signaling in growth and metabolism. Cell 2006; 124: 471-484. (Pubitemid 43199434)
13. Powell JD, Delgoffe GM,. The mammalian target of rapamycin: Linking T cell differentiation, function, and metabolism. Immunity 2010; 33: 301-311.
14. Araki K, Turner AP, Shaffer VO, et al,. mTOR regulates memory CD8 T-cell differentiation. Nature 2009; 460: 108-112.
15. Pearce EL, Walsh MC, Cejas PJ, et al,. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 2009; 460: 103-107.
16. Rao RR, Li Q, Odunsi K, Shrikant PA,. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 2010; 32: 67-78.
17. Greenberg ME, Lai MH, Hartel GF, et al,. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361: 2405-2413.
18. Rowe T, Abernathy RA, Hu-Primmer J, et al,. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999; 37: 937-943. (Pubitemid 29140593)
19. Mawhorter S, Yamani MH,. Hypogammaglobulinemia and infection risk in solid organ transplant recipients. Curr Opin Organ Transplant 2008; 13: 581-585.
20. Clark TW, Pareek M, Hoschler K, et al,. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361: 2424-2435.
21. Zhu FC, Wang H, Fang HH, et al,. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361: 2414-2423.
22. Liu WM, Zeijst BA, Boog CJ, Soethout EC,. Aging and impaired immunity to influenza viruses: Implications for vaccine development. Hum Vaccin 2011; 7(Suppl 1-2): S1-S5.
23. Hancock K, Veguilla V, Lu X, et al,. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361: 1945-1952.
24. Vilchez RA, McCurry K, Dauber J, et al,. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 287-291. (Pubitemid 36330248)
25. Danziger-Isakov LA, Husain S, Mooney ML, Hannan MM,. The novel 2009 H1N1 influenza virus pandemic: Unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant 2009; 28: 1341-1347.
26. San Segundo D, Fernandez-Fresnedo G, Gago M, et al,. Number of peripheral blood regulatory T cells and lymphocyte activation at 3 months after conversion to mTOR inhibitor therapy. Transplant Proc 2010; 42: 2871-2873.
27. Lages CS, Suffia I, Velilla PA, et al,. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 2008; 181: 1835-1848.